1.35 (-%)
As of Nov 12, 2024
Source:
Nanoviricides, Inc. is engaged in the application of nanomedicine technologies to the complex issues of viral diseases. We are developing a class of drugs, that we call nanoviricides™, using a platform technology. T
| Country | United States |
| Headquarters | shelton, connecticut |
| Phone Number | (203) 937-6137 |
| Industry | manufacturing |
| CEO | Anil Diwan |
| Website | http://www.nanoviricides.com |